Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
521 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2019
522 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2019
523 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute 		Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2019
524 Complication versus Radicality in Papillary Thyroid Cancer Surgery: How to Keep the Balance? Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2019
525 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Clinical Pathology Asmaa Ahmed Mohamed ahmed 2019
526 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
527 Sensitvity of flowcytometry immunphenotyping compared to Bone marrow morphology in diagnosis of multiple myeloma Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2019
528 Pediatric Osteosarcoma of Extremities: a 15-year Experience from a Tertiary Care Cancer Center in Upper Egypt Department of Pathology Dr. Rania Ahmed Abdallah Mohamed 2019
529 Dexmedetomidine versus midazolam as an adjuvant sedating agent for bone marrow aspiration in pediatric patients. Department of Anesthesia, Intensive care and Pain management Mohamed Hussein Mahmoud Ahmed 2019
530 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019